No Data
No Data
Terns Pharmaceuticals Director Buys $5 Million in Company Stock
Terns Pharmaceuticals(TERN.US) Director Buys US$5 Million in Common Stock
$Terns Pharmaceuticals(TERN.US)$ Director Lu Hongbo purchased 476.19K shares of common stock on Sep 12, 2024 at an average price of $10.5 for a total value of $5 million.Source: Announcement What is
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc
With 55% Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Boasts of Strong Institutional Backing
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Raises Target Price to $26
BMO Capital analyst Etzer Darout maintains $Terns Pharmaceuticals(TERN.US)$ with a buy rating, and adjusts the target price from $19 to $26.According to TipRanks data, the analyst has a success rate
Express News | Terns Pharmaceuticals Inc : BMO Raises Target Price to $26 From $19